WASHINGTON, Jan 3 (Reuters) - The U.S. Food and Drug Administration has warned medical device maker Viasys Healthcare Inc. (VAS.N: Quote, Profile , Research) over its failure to implement certain review procedures for its air pressure devices used to improve breathing, according to a letter released on Wednesday.
